Trending menu:
News
-
18 February 2020
Recardio to continue Phase II trial of dutogliptin
Life science company Recardio is set to continue the Phase II clinical trial of its dutogliptin drug in combination with filgrastim in severe heart attack patients.
-
18 February 2020
Coronavirus: Chloroquine yields positive data in Covid-19 trial
Early data from clinical trials being performed in China has revealed that chloroquine phosphate could help treat the new coronavirus disease, Covid-19.
-
18 February 2020
China approves first anti-viral drug against coronavirus Covid-19
Anti-viral drug Favilavir has secured approval from the National Medical Products Administration of China to treat coronavirus Covid-19, according to media reports.
-
17 February 2020
BMS reports Phase III data of Opdivo plus Yervoy in renal cancer
Bristol-Myers Squibb (BMS) has reported additional positive data from the Phase III CheckMate-214 clinical trial of Opdivo (nivolumab) in combination with Yervoy (ipilimumab) in patients with treatment-naïve advanced or metastatic...
-
17 February 2020
Weill Cornell Medicine secures funding for HPV cancer investigation
Weill Cornell Medicine in the US has secured funding to investigate ways to prevent cancers related to human papillomavirus (HPV) in people living with human immunodeficiency virus (HIV) infection.
-
17 February 2020
UCL researchers test cough syrup drug for Parkinson’s
A research team at University College London has secured funding to evaluate the use of cough syrup drug ambroxol to treat Parkinson’s disease patients in clinical trials.
-
17 February 2020
Janssen’s Stelara shows remission in Crohn’s disease patients
Interim results from the Phase IIIb STARDUST clinical trial have revealed that Janssen Pharmaceutical’s Stelara (ustekinumab) led to clinical remission in moderately to severely active Crohn's disease (CD) patients.
-
14 February 2020
Evgen and Rochester University partner to advance SFX-01 trial
Evgen Pharma has signed a memorandum of understanding (MoU) with the University of Rochester School of Medicine & Dentistry to advance SFX-01 towards a clinical study for treating patients with...
-
14 February 2020
Annovis Bio to continue DISCOVER Alzheimer’s trial
Drug platform company Annovis Bio is set to continue its Phase II DISCOVER clinical trial of ANVS401 in patients suffering from Alzheimer’s disease.
-
14 February 2020
ImmunogenX starts enrolment in Phase IIb celiac disease study
Biotherapeutics company ImmunogenX has commenced patient enrolment in a Phase IIb clinical trial of Latiglutenase (IMGX003) for the treatment of celiac disease.